 | Up a level |
Armstrong, Jane, Martin, S, Illingworth, N A, Jamieson, D, Neilson, A, Lovat, PE, Redfern, CPF and Veal, GJ (2011) The impact of retinoic acid treatment on the sensitivity of neuroblastoma cells to fenretinide. Oncology Reports, 27. pp. 293-298. ISSN 1791-2431
Armstrong, Jane, Corazzari, M, Martin, S, Pagliarini, V, Falasca, L, Hill, D S, Ellis, N, Al Sabah, S, Redfern, C P F, Fimia, G M, Piacentini, M and Lovat, P E (2011) Oncogenic B-RAF signalling in melanoma impairs the therapeutic advantage of autophagy inhibition. Clinical Cancer Research, 17 (8). pp. 2216-2226. ISSN 1078-0432
Hiscutt, E L, Hill, D S, Martin, S, Kerr, R, Harbottle, A, Simpson, D, Birch-Machin, M A, Redfern, C P F, Fulda, S, Armstrong, Jane and Lovat, P E (2010) Targeting XIAP to increase the efficacy of endoplasmic reticulum stress-induced apoptosis for melanoma therapy. Journal Of Investigative Dermatology, 130. pp. 2250-2258. ISSN 0022-202X
Hill, D S, Martin, S, Armstrong, Jane, Flockhart, R, Tonison, J J, Simpson, D G, Birch-Machin, M A, Redfern, C P F and Lovat, P E (2009) Combining the ER stress-inducing agents bortezomib and fenretinide as a novel therapeutic strategy for metastatic melanoma. Clinical Cancer Research, 15 (4). pp. 1192-1198. ISSN 1078-0432
Armstrong, Jane, Lovat, P E, Corazzari, M, Martin, S, Pagliarini, V, Hill, D, Piacentini, M, Birch-Machin, M A and Redfern, C P F (2008) Increasing melanoma cell death using inhibitors of protein disulphide isomerases to abrogate survival responses to endoplasmic reticulum stress. Cancer Research, 68. pp. 5363-5369. ISSN 0008-5472